Phase1 Study of TS-141 in Healthy Volunteers
Phase 1
Completed
- Conditions
- -
- Registration Number
- JPRN-jRCT2080225139
- Lead Sponsor
- Taisho Pharmaceutical Co.Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Male
- Target Recruitment
- 48
Inclusion Criteria
Healthy Volunteers
Exclusion Criteria
Patients with a current medical history or medical history deemed inappropriate for participation in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>pharmacokinetics<br>To investigate Pharmacokinetics parameter of TS-141 and its metabolite<br>To investigate incidence of Treatment-emergent Adverse Events and Serious AEs, vital-sign, weight, 12-leads ECG and clinical laboratory test
- Secondary Outcome Measures
Name Time Method